Area of research
Cell Biology · Molecular Biology
Research interest
Research interests include Medicine, Heparanase, Cancer research, Cancer, Breast cancer, and Inflammation.
Effective head and neck cancer treatment combines radiation and local extended cisplatin release
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase
Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma
Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations
Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
Dissecting the role of crosstalk between glioblastoma subpopulations in tumor cell spreading
Dichotomic role of heparanase in a murine model of metabolic syndrome
p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression
Periodontal pathogens <i>Porphyromonas gingivalis</i> and <i>Fusobacterium nucleatum</i> promote tumor progression in an oral-specific chemical carcinogenesis model
Role of Heparanase-Driven Inflammatory Cascade in Pathogenesis of Diabetic Nephropathy
Induction of heparanase by <scp>HPV</scp> E6 oncogene in head and neck squamous cell carcinoma
Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice